Centre of Excellence in blood cancer research unveiled in Cambridge

The University of Cambridge has been named as a Centre of Excellence by the national blood cancer charity Leukaemia & Lymphoma Research. A plaque was unveiled today (Tuesday, 7 September) at the Clinical School. A second plaque was also unveiled at Addenbrooke's Hospital, where many of the charity's researchers are also clinicians. The charity has £9.5 million currently invested in 23 research projects at the Centre, which has been recognised for its world-class research into how blood cancers develop, as well as research into new treatments and improvements in diagnosis for lymphoma and some of the rarer blood cancers. Cambridge is home to some of the world's leading specialists in the myeloproliferative neoplasms (MPN), a group of blood disorders related to leukaemia that affect around 3,300 people in the UK every year. Sustained investment by the charity at Cambridge has led to significant improvements in the diagnosis for MPN patients. Scientists work closely with doctors at Addenbrooke's Hospital to ensure that any breakthroughs in diagnosis benefit blood cancer patients across Cambridge and the surrounding area as soon as possible.